Treatment with the Topical Antimicrobial Peptide Omiganan in Mild-to-Moderate Facial Seborrheic Dermatitis versus Ketoconazole and Placebo: Results of a Randomized Controlled Proof-of-Concept Trial. - Rousel J; Saghari M; Pagan L; Nădăban A; Gambrah T; Theelen B; de Kam ML; Haakman J; van der Wall HEC; Feiss GL; Niemeyer-van der Kolk T; Burggraaf J; et al. (International journal of molecular sciences, 2023)